Health Catalyst
Financials
Estimates*
USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 189m | 242m | 276m | 296m | 308m | 343m | 382m |
% growth | 22 % | 28 % | 14 % | 7 % | 4 % | 11 % | 11 % |
EBITDA | (77.4m) | (106m) | (91.7m) | (68.3m) | 25.2m | 37.0m | 50.1m |
% EBITDA margin | (41 %) | (44 %) | (33 %) | (23 %) | 8 % | 11 % | 13 % |
Profit | (115m) | (153m) | (137m) | (118m) | (60.3m) | (46.3m) | (31.5m) |
% profit margin | (61 %) | (63 %) | (50 %) | (40 %) | (20 %) | (14 %) | (8 %) |
EV / revenue | 9.3x | 7.4x | 1.6x | 1.5x | 2.5x | 2.2x | 1.9x |
EV / EBITDA | -22.6x | -16.9x | -4.8x | -6.5x | 30.2x | 20.5x | 14.5x |
R&D budget | 53.5m | 62.7m | 75.7m | 72.6m | - | - | - |
R&D % of revenue | 28 % | 26 % | 27 % | 25 % | - | - | - |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | N/A | Series A | |
$33.0m | Series B | ||
$8.0m | Series B | ||
$41.0m | Series C | ||
$70.0m | Series D | ||
$70.0m | Late VC | ||
N/A | Series E | ||
* | $15.0m Valuation: $1.0b 8.9x EV/LTM Revenues -19.0x EV/LTM EBITDA | Series F | |
$85.0m Valuation: $1.0b 8.9x EV/LTM Revenues -19.0x EV/LTM EBITDA | Debt | ||
N/A | N/A Valuation: $1.3b 11.5x EV/LTM Revenues -24.7x EV/LTM EBITDA | IPO | |
* | N/A | $200m | Post IPO Convertible |
N/A | $50.0m | Post IPO Equity | |
N/A | $13.5m | Post IPO Equity | |
* | N/A | Post IPO Equity | |
* | N/A | $2.5m | Post IPO Equity |
Total Funding | €215m |
Related Content
Recent News about Health Catalyst
EditHealth Catalyst is a healthcare technology company that specializes in data and analytics solutions. The company operates in the healthcare sector, serving a wide range of clients including hospitals, healthcare providers, life sciences organizations, and insurance companies. Health Catalyst's primary market is the United States, but it also has a growing presence internationally.
The core of Health Catalyst's business is its Data Operating System (DOS), a platform that integrates and organizes vast amounts of healthcare data. This system allows healthcare organizations to analyze data more effectively, leading to improved patient outcomes and operational efficiency. The company also offers a suite of analytics applications powered by artificial intelligence (AI) and machine learning, which help clients make data-driven decisions.
Health Catalyst's business model is based on a combination of software-as-a-service (SaaS) and professional services. Clients typically subscribe to the DOS platform and analytics applications on a recurring basis. Additionally, Health Catalyst provides consulting services to help organizations implement and optimize their data strategies. This dual revenue stream ensures a steady flow of income while also fostering long-term client relationships.
The company makes money primarily through subscription fees for its software platform and analytics tools. It also generates revenue from professional services, which include implementation, training, and ongoing support. By helping healthcare organizations improve clinical, financial, and operational outcomes, Health Catalyst adds significant value, justifying its subscription and service fees.
In summary, Health Catalyst is a key player in the healthcare technology market, offering data and analytics solutions that drive better patient care and operational efficiency. Its business model combines recurring software subscriptions with professional services, ensuring a stable and growing revenue stream.
Keywords: Healthcare, Data Analytics, AI, Machine Learning, SaaS, Professional Services, Data Integration, Patient Outcomes, Operational Efficiency, Healthcare Technology.